Exhibit
4.1


 


THIS
WARRANT AND THE WARRANT SHARES ISSUED UPON ITS EXERCISE ARE SUBJECT TO THE RESTRICTIONS ON TRANSFER SET FORTH IN SECTION 5 OF THIS WARRANT.


 


	Warrant
    No.: PA-[●]	Number
    of Shares: [●] 
	 	(subject
    to adjustment)
	Date
    of Issuance: [●], 2022	 
	 	 
	Original
    Issue Date: [●], 2022	 
	(as
    defined in subsection 2(b))	 
	 	 
	Holder:
    [●]


 


Celcuity
Inc.


 


Stock
Purchase Warrant


 


(Void
after 5:00 p.m. (New York City time) on [●], 2027,


subject
to earlier termination as provided herein)


 


Celcuity
Inc., a Delaware corporation (the “Company”), for value received, hereby certifies that the Holder named above, or
its registered assigns (the “Registered Holder”), is entitled, subject to the terms and conditions set forth below,
to purchase from the Company, at any time or from time to time on or after the date of issuance and on or before the expiration of the
Exercise Period (as defined below), up to [●] shares of Series A Preferred Stock (as defined below) at a purchase price of $80.50
per share. The shares purchasable upon exercise of this Warrant, and the purchase price per share, each as adjusted from time to time
pursuant to the provisions of this Warrant, are hereinafter referred to as the “Warrant Shares” and the “Purchase
Price,” respectively. This Warrant is one of the Stock Purchase Warrants (the “Warrants”) issued pursuant
to that certain Securities Purchase Agreement dated as of May 15, 2022, by and among the Company and each of the investors party thereto
(the “Purchase Agreement”). Capitalized terms used herein have the respective meanings ascribed thereto in the Purchase
Agreement unless otherwise defined herein.


 


“Series
A Preferred Stock” means the Series A Convertible Preferred Stock, par value $0.001 per share, of the Company, having the rights,
preferences and privileges specified in the Certificate of Designations, which will be convertible into Common Stock, $0.001 par value
per share, of the Company (“Common Stock”) in accordance with the terms set forth in the Certificate of Designations.


 


1.
Exercise.


 


(a)
Exercise Period. This Warrant may be exercised at any time or from time to time on or after the date of issuance and on or before
the earlier of (i) 5:00 p.m. (New York City time) on [●], 2027 or (ii) seventy-five (75) days after the Company publicly announces
(x) whether the progression-free survival (PFS) of gedatolisib in combination with palbociclib and fulvestrant (Arm A) to fulvestrant
(Arm C) in the Phase 3 study met its primary endpoint target, (y) whether the PFS of gedatolisib in combination with fulvestrant (Arm
B) to fulvestrant (Arm C) in the Phase 3 study met its primary endpoint target, and (z) the associated hazard ratios and median PFS values
for each of Arm A, Arm B, and Arm C (the “Exercise Period”).


 




    	 



     


    

 


(b)
Exercise for Common Stock. Without limiting the provisions of Section 2, upon written notice from the Company as provided in Section
2(a), (i) prior to the Adjustment Date specified in such notice this Warrant will be exercisable for Series A Preferred Stock subject
to the Beneficial Ownership Limitation (as defined below); and (ii) from and after the Adjustment Date specified in such notice this
Warrant will be exercisable for Common Stock instead of Series A Preferred Stock, the Purchase Price will be adjusted as provided in
Section 2(a), and all references to the Warrant Shares and the Purchase Price will mean Common Stock and the Purchase Price as so adjusted.


 


(c)
Exercise for Cash. Subject to the Beneficial Ownership Limitation set forth in Section 1(f), the Registered Holder may elect to
exercise this Warrant, in whole or in part and at any time or from time to time, by surrendering this Warrant, with the purchase form
appended hereto as Exhibit A duly executed by or on behalf of the Registered Holder, at the principal office of the Company, or
at such other office or agency as the Company may designate, accompanied by payment in full, in lawful money of the United States, of
the Purchase Price payable in respect of the number of Warrant Shares purchased upon such exercise.


 


(d)
Exercise Date. Each exercise of this Warrant shall be deemed to have been effected immediately prior to the close of business
on the day on which this Warrant shall have been surrendered to the Company as provided in subsection 1(c) above (the “Exercise
Date”). At such time, the person or persons in whose name or names any certificates for Warrant Shares shall be issuable upon
such exercise as provided in subsection 1(e) below shall be deemed to have become the holder or holders of record of the Warrant Shares
represented by such certificates.


 


(e)
Issuance Upon Exercise. As soon as practicable after the exercise of this Warrant in whole or in part, and in any event within
5 days thereafter, the Company, at its expense, will cause to be issued in the name of, and delivered to, the Registered Holder, or as
the Registered Holder (upon payment by the Registered Holder of any applicable transfer taxes) may direct:


 


(i)
a certificate or certificates for the number of full Warrant Shares to which the Registered Holder shall be entitled upon such exercise
transmitted by the transfer agent of the Company to the Registered Holder in electronic book entry form to the account of such Registered
Holder or, upon request of the Registered Holder, by physical delivery to the address specified by the Registered Holder, plus, in lieu
of any fractional share to which the Registered Holder would otherwise be entitled, cash in an amount determined pursuant to Section
3 hereof; and


 


(ii)
in case such exercise is in part only, a new warrant or warrants (dated the date hereof) of like tenor, calling in the aggregate on the
face or faces thereof for the number of Warrant Shares equal (without giving effect to any adjustment therein) to the number of such
shares called for on the face of this Warrant minus the number of Warrant Shares for which this Warrant was so exercised.


 




    	2



     


    

 


(f)
Beneficial Ownership Limitation. Notwithstanding anything herein to the contrary, the Company shall not effect the exercise of
this Warrant, and the Registered Holder shall not have the right to exercise this Warrant, to the extent that after giving effect to
such exercise, such Registered Holder (together with such Registered Holder’s Affiliates (that is, any person that, directly or
indirectly through one or more intermediaries, controls or is controlled by or is under common control with a Person, as such terms are
used in and construed under Rule 405 of the Securities Act of 1933, as amended), and any other person whose beneficial ownership of Common
Stock would be aggregated with the Registered Holder’s for purposes of Section 13(d) or Section 16 of the Securities Exchange Act
of 1934, as amended (the “Exchange Act”) and the applicable regulations of the United States Securities and Exchange
Commission (the “Commission”), including any “group” of which the Registered Holder is a member (the foregoing,
“Attribution Parties”)) would beneficially own a number of shares of Common Stock in excess of the Beneficial Ownership
Limitation (as defined below). For purposes of the foregoing sentence, the number of shares of Common Stock beneficially owned by such
Registered Holder and its Attribution Parties shall include the number of shares of Common Stock issuable upon exercise of this Warrant
(assuming the conversion of Warrant Shares into Common Stock and assuming the authorization of such Common Stock to be issued for the
purposes of such calculation) with respect to which the determination of such sentence is being made, but shall exclude shares of Common
Stock (or Warrant Shares convertible into Common Stock) which would be issuable upon (i) exercise of the remaining, unexercised portion
of this Warrant beneficially owned by such Registered Holder and its Affiliates and (ii) exercise or conversion of the unexercised or
unconverted portion of any other securities of the Company beneficially owned by such Registered Holder and its Affiliates (including,
without limitation, any convertible notes or convertible preferred stock or warrants) subject to a limitation on conversion or exercise
analogous to the limitation contained herein. For purposes of this Section 1(f), beneficial ownership shall be calculated in accordance
with Section 13(d) of the Exchange Act and the applicable regulations of the Commission. In addition, for purposes hereof, “group”
has the meaning set forth in Section 13(d) of the Exchange Act and the applicable regulations of the Commission. For purposes of this
Section 1(f), in determining the number of outstanding shares of Common Stock, a Registered Holder may rely on the number of outstanding
shares of Common Stock as stated in the most recent of the following: (A) the Company’s most recent periodic or annual filing with
the Commission, as the case may be, (B) a more recent public announcement by the Company that is filed with the Commission, or (C) a
more recent notice by the Company or the Company’s transfer agent to the Registered Holder setting forth the number of shares of
Common Stock then outstanding. Upon the written request of a Registered Holder (which may be by email), the Company shall, within three
(3) Trading Days thereof, confirm in writing to such Registered Holder (which may be via email) the number of shares of Common Stock
then outstanding. In any case, the number of outstanding shares of Common Stock shall be determined after giving effect to any actual
conversion or exercise of securities of the Company, including the Warrants, by the Registered Holder or its Attribution Parties since
the date as of which such number of outstanding shares of Common Stock was last publicly reported or confirmed to the Registered Holder.
The “Beneficial Ownership Limitation” shall initially be set at 9.9% of the number of shares of the Common Stock outstanding
immediately after giving effect to the issuance of shares of Common Stock pursuant to such exercise (to the extent permitted pursuant
to this Section 1(f)). The Company shall be entitled to rely on representations made to it by the Registered Holder regarding its Beneficial
Ownership Limitation. Notwithstanding the foregoing, (i) by written notice to the Company, which will not be effective until the sixty-first
(61st) day after such written notice is delivered to the Company, the Registered Holder may reset the Beneficial Ownership Limitation
percentage to a higher percentage, not to exceed 19.9%, to the extent then applicable and (ii) by written notice to the Company, which
will be effective immediately after such notice is delivered to the Company, the Registered Holder may reset the Beneficial Ownership
Limitation percentage to a lower percentage. Any such increase or decrease will apply only to the Registered Holder and not to any other
holder of Warrants. Upon such a change by a Registered Holder of the Beneficial Ownership Limitation, the Beneficial Ownership Limitation
may not be further amended by such Registered Holder without first providing the minimum notice required by this Section 1(f).


 




    	3



     


    

 


Notwithstanding
the foregoing, at any time following notice of a Fundamental Transaction, the Registered Holder may waive and/or change the Beneficial
Ownership Limitation effective immediately upon written notice to the Company and may reinstitute a Beneficial Ownership Limitation at
any time thereafter effective immediately upon written notice to the Company. “Fundamental Transaction” means that
(A) the Company shall, directly or indirectly, in one or more related transactions, (i) consolidate or merge with or into (whether or
not the Company is the surviving corporation) another Person, or (ii) sell, assign, transfer, convey or otherwise dispose of all or substantially
all of the properties or assets of the Company to another Person, or (iii) allow another Person to make a purchase, tender or exchange
offer that is accepted by the holders of more than 50% of the outstanding shares of Common Stock (not including any shares of Common
Stock held by the Person or Persons making or party to, or associated or affiliated with the Persons making or party to, such purchase,
tender or exchange offer), or (iv) execute a stock purchase agreement or other business combination (including, without limitation, a
reorganization, recapitalization, spin-off or scheme of arrangement) with another Person whereby such other Person acquires more than
50% of the outstanding shares of Common Stock (not including any shares of Common Stock held by the other Person or other Persons making
or party to, or associated or affiliated with the other Persons making or party to, such stock purchase agreement or other business combination)
or (B) any “person” or “group” (as these terms are used for purposes of Sections 13(d) and 14(d) of the 1934
Act) is or shall become the “beneficial owner” (as defined in Rule 13d-3 under the 1934 Act), directly or indirectly, of
more than 50% of the aggregate ordinary voting power represented by issued and outstanding Common Stock.


 


2.
Adjustments.


 


(a)
Adjustment upon Authorized Share Increase. Upon written notice from the Company to all Registered Holders of Warrants that an
amendment to, or amendment and restatement of, the Company’s Certificate of Incorporation has become effective that increases the
aggregate number of shares of capital stock and the number of shares of Common Stock the Company has authority to issue such that the
Company has available, and has reserved, such number of its duly authorized but unissued shares of Common Stock as shall be sufficient
to effect the conversion of all shares of Series A Preferred Stock then outstanding or available for issuance upon the exercise of this
Warrant and all other Warrants, then from and after the date specified in such notice (the “Adjustment Date”), this
Warrant shall be exercisable for that number of shares of Common Stock equal to the number of shares of Common Stock that would have
been received if this Warrant had been exercised in full and the Series A Preferred Stock received thereupon had been simultaneously
converted into Common Stock immediately prior to the Adjustment Date, and the Purchase Price shall be adjusted to equal the quotient
obtained by dividing: (x) the aggregate Purchase Price of the maximum number of shares of Series A Preferred Stock for which this Warrant
was exercisable immediately prior to the Adjustment Date, by (y) the number of shares of Common Stock for which this Warrant is exercisable
immediately after the Adjustment Date, all subject to further adjustment thereafter from time to time in accordance with the provisions
of this Warrant.


 


(b)
Adjustment for Stock Splits and Combinations. If the Company shall at any time or from time to time after the date on which this
Warrant was first issued (or, if this Warrant was issued upon partial exercise of, or in replacement of, another warrant of like tenor,
then the date on which such original warrant was first issued) (either such date being referred to as the “Original Issue Date”)
effect a subdivision of the outstanding shares of the same class and series as the Warrant Shares, the Purchase Price then in effect
immediately before that subdivision shall be proportionately decreased. If the Company shall at any time or from time to time after the
Original Issue Date combine the outstanding shares of the same class and series as the Warrant Shares, the Purchase Price then in effect
immediately before the combination shall be proportionately increased. Any adjustment under this paragraph shall become effective at
the close of business on the date the subdivision or combination becomes effective.


 


(c)
Adjustment for Certain Dividends and Distributions. If the Company shall at any time, or from time to time after the Original
Issue Date shall make or issue, or fix a record date for the determination of holders of outstanding shares of the same class and series
as the Warrant Shares entitled to receive, a dividend or other distribution payable in additional shares of the same class and series
as the Warrant Shares, then and in each such event the Purchase Price then in effect immediately before such event shall be decreased
as of the time of such issuance or, in the event such a record date shall have been fixed, as of the close of business on such record
date, by multiplying the Purchase Price then in effect immediately before such event by a fraction:


 


(1)
the numerator of which shall be the total number of shares of the same class and series as the Warrant Shares issued and outstanding
immediately prior to the time of such issuance or the close of business on such record date, and


 








    	4



     


    

 


(2)
the denominator of which shall be the total number of shares of the same class and series as the Warrant Shares issued and outstanding
immediately prior to the time of such issuance or the close of business on such record date plus the number of shares of such
class and series issuable in payment of such dividend or distribution;


 


provided,
however, that if such record date shall have been fixed and such dividend is not fully paid or if such distribution is not fully
made on the date fixed therefor, the Purchase Price shall be recomputed accordingly as of the close of business on such record date and
thereafter the Purchase Price shall be adjusted pursuant to this paragraph as of the time of actual payment of such dividends or distributions.


 


(d)
Adjustment in Number of Warrant Shares. When any adjustment is required to be made in the Purchase Price pursuant to subsections
2(a), 2(b) or 2(c), the number of Warrant Shares purchasable upon the exercise of this Warrant shall be changed to the number determined
by dividing (i) an amount equal to the number of shares issuable upon the exercise of this Warrant immediately prior to such adjustment,
multiplied by the Purchase Price in effect immediately prior to such adjustment, by (ii) the Purchase Price in effect immediately after
such adjustment.


 


(e)
Adjustments for Other Dividends and Distributions. In the event the Company at any time
or from time to time after the Original Issue Date shall make or issue, or fix a record date for the determination of holders of
outstanding shares of the same class and series as the Warrant Shares entitled to receive, a dividend
or other distribution payable in securities of the Company (other than shares of the same class and series as the Warrant Shares)
or in cash or other property (other than regular cash dividends paid out of earnings or earned surplus, determined in accordance with
generally accepted accounting principles), then and in each such event provision shall be made so that the Registered Holder shall receive
upon exercise hereof, in addition to the number of Warrant Shares issuable hereunder, the kind and amount of securities of the Company,
cash or other property which the Registered Holder would have been entitled to receive had this Warrant been exercised on the date of
such event and had the Registered Holder thereafter, during the period from the date of such event to and including the Exercise Date,
retained any such securities receivable during such period, giving application to all adjustments called for during such period under
this Section 2 with respect to the rights of the Registered Holder.


 


(f)
Adjustment for Reorganization. If there shall occur any reorganization, recapitalization, reclassification, consolidation or merger
involving the Company in which the outstanding shares of the same class and series as the Warrant Shares are converted into or exchanged
for securities, cash or other property (other than a transaction covered by subsections 2(a), 2(b) or 2(c) (collectively, a “Reorganization”),
then, following such Reorganization, the Registered Holder shall receive upon exercise hereof the kind and amount of securities, cash
or other property which the Registered Holder would have been entitled to receive pursuant to such Reorganization if such exercise had
taken place immediately prior to such Reorganization. In any such case, appropriate adjustment (as determined in good faith by the Board)
shall be made in the application of the provisions set forth herein with respect to the rights and interests thereafter of the Registered
Holder, to the end that the provisions set forth in this Section 2 (including provisions with respect to changes in and other adjustments
of the Purchase Price) shall thereafter be applicable, as nearly as reasonably may be, in relation to any securities, cash or other property
thereafter deliverable upon the exercise of this Warrant.


 




    	5



     


    

 


(g)
Certificate as to Adjustments. Upon the occurrence of each adjustment or readjustment of the Purchase Price pursuant to this Section
2, the Company at its expense shall, as promptly as reasonably practicable but in any event not later than 10 days thereafter, compute
such adjustment or readjustment in accordance with the terms hereof and furnish to the Registered Holder a certificate setting forth
such adjustment or readjustment (including the kind and amount of securities, cash or other property for which this Warrant shall be
exercisable and the Purchase Price). The Company shall, as promptly as reasonably practicable after the written request at any time of
the Registered Holder (but in any event not later than 10 days thereafter), furnish or cause to be furnished to the Registered Holder
a certificate setting forth (i) the Purchase Price then in effect and (ii) the number of Warrant Shares and the amount, if any, of other
securities, cash or property which then would be received upon the exercise of this Warrant.


 


(h)
All calculations under this Section 2 shall be made to the nearest cent or the nearest 1/100th of a share, as the case may be.


 


3.
Fractional Shares. The Company shall not be required to issue any fractional shares upon the exercise of this Warrant. As to any
fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the Company shall, at its election,
either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied by the Purchase Price or
round up to the next whole share.


 


4.
Investment Representations. The initial Registered Holder represents and warrants to the Company as follows:


 


(a)
Investment. The Registered Holder is acquiring the Warrant, and (if and when the Registered Holder exercises this Warrant) the
Registered Holder will acquire the Warrant Shares, for the Registered Holder’s own account for investment and not with a view to,
or for sale in connection with, any distribution thereof, nor with any present intention of distributing or selling the same; and the
Registered Holder has no present or contemplated agreement, undertaking, arrangement, obligation, indebtedness or commitment providing
for the disposition thereof.


 


(b)
Accredited Investor. The Registered Holder is an “accredited investor” as defined in Rule 501(a) under the
1933 Act.


 


(c)
Experience. The Registered Holder has made such inquiry concerning the Company and its business and personnel the Registered Holder
he has deemed appropriate; and the Registered Holder has sufficient knowledge and experience in finance and business that the Registered
Holder is capable of evaluating the risks and merits of the Registered Holder’s investment in the Company.


 


5.
Transfers, etc.


 


(a)
This Warrant and the Warrant Shares shall not be sold or transferred unless either (i) they first shall have been registered under the
Act, or (ii) the Company first shall have been furnished with an opinion of legal counsel, reasonably satisfactory to the Company, to
the effect that such sale or transfer is exempt from the registration requirements of the Act.


 


(b)
The Registered Holder acknowledges and agrees that the Warrant Shares shall be subject to the restrictive legend requirements set forth
in the Purchase Agreement.


 


(c)
The Company will maintain a register containing the name and address of the Registered Holder of this Warrant. The Registered Holder
may change the Registered Holder’s address as shown on the warrant register by written notice to the Company requesting such change.


 




    	6



     


    

 


(d)
Subject to the provisions of Section 5 hereof, this Warrant and all rights hereunder are transferable, in whole or in part, upon surrender
of this Warrant with a properly executed assignment (in the form of Exhibit B hereto) at the principal office of the Company (or,
if another office or agency has been designated by the Company for such purpose, then at such other office or agency).


 


6.
Notices of Record Date, etc. In the event:


 


(a)
the Company shall take a record of the holders of outstanding shares of the same class and series as the Warrant Shares (or other stock
or securities at the time deliverable upon the exercise of this Warrant) for the purpose of entitling or enabling them to receive any
dividend or other distribution, or to receive any right to subscribe for or purchase any shares of stock of any class or any other securities,
or to receive any other right; or


 


(b)
of any capital reorganization of the Company, any reclassification of the shares of the same class and series as the Warrant Shares,
any consolidation or merger of the Company with or into another corporation (other than a consolidation or merger in which the Company
is the surviving entity and the outstanding shares of the same class and series as the Warrant Shares are not converted into or exchanged
for any other securities or property), or any transfer of all or substantially all of the assets of the Company; or


 


(c)
of the voluntary or involuntary dissolution, liquidation or winding-up of the Company,


 


then,
and in each such case, the Company will send or cause to be sent to the Registered Holder a notice specifying, as the case may be, (i)
the record date for such dividend, distribution or right, and the amount and character of such dividend, distribution or right, or (ii)
the effective date on which such reorganization, reclassification, consolidation, merger, transfer, dissolution, liquidation or winding-up
is to take place, and the time, if any is to be fixed, as of which the holders of record of outstanding shares of the same class and
series as the Warrant Shares (or such other stock or securities at the time deliverable upon the exercise of this Warrant) shall be entitled
to exchange their shares of such class and series (or such other stock or securities) for securities or other property deliverable upon
such reorganization, reclassification, consolidation, merger, transfer, dissolution, liquidation or winding-up. Such notice shall be
sent at least 3 days prior to the record date or effective date for the event specified in such notice, and the Registered Holder shall
keep any such notice confidential.


 


7.
Reservation of Stock. The Company will at all times reserve and keep available, solely for issuance and delivery upon the exercise
of this Warrant, such number of Warrant Shares and other securities, cash and/or property, as from time to time shall be issuable upon
the exercise of this Warrant. Such reservation shall comply without regard to the provisions of Section 1(f).


 


8.
Exchange or Replacement of Warrants.


 


(a)
Upon the surrender by the Registered Holder, properly endorsed, to the Company at the principal office of the Company, the Company will,
subject to the provisions of Section 5 hereof, issue and deliver to or upon the order of the Registered Holder, at the Company’s
expense, a new Warrant or Warrants of like tenor, in the name of the Registered Holder or as the Registered Holder (upon payment by the
Registered Holder of any applicable transfer taxes) may direct, calling in the aggregate on the face or faces thereof for the number
of Warrant Shares (or other securities, cash and/or property) then issuable upon exercise of this Warrant.


 




    	7



     


    

 


(b)
Upon receipt of evidence reasonably satisfactory to the Company of the loss, theft, destruction or mutilation of this Warrant and (in
the case of loss, theft or destruction) upon delivery of an indemnity agreement (with surety if reasonably required) in an amount reasonably
satisfactory to the Company, or (in the case of mutilation) upon surrender and cancellation of this Warrant, the Company will issue,
in lieu thereof, a new Warrant of like tenor.


 


9.
Notices. All notices and other communications from the Company to the Registered Holder in connection herewith shall be mailed
by certified or registered mail, postage prepaid, or sent via a reputable nationwide overnight courier service guaranteeing next business
day delivery, or sent by electronic mail, to the address or electronic mail address last furnished to the Company in writing by the Registered
Holder. All notices and other communications from the Registered Holder to the Company in connection herewith shall be mailed by certified
or registered mail, postage prepaid, or sent via a reputable nationwide overnight courier service guaranteeing next business day delivery,
to the Company at its principal office set forth below:


 


Celcuity
Inc.


16305
36th Avenue North, Suite 100


Minneapolis,
MN 55446


Attention:
Brian F. Sullivan and Vicky Hahne


E-mail:
bsullivan@celcuity.com; vhahne@celcuity.com


 


With
a copy (which will not constitute notice) to:


 


Fredrikson
& Byron, P.A.


200
South Sixth Street, Suite 4000


Minneapolis,
MN 55402


Facsimile:
(612) 492-7077


Attention:
Eric O. Madson


E-mail:
emadson@fredlaw.com


 


If
the Company should at any time change the location of its principal office to a place other than as set forth above, it shall give prompt
written notice to the Registered Holder and thereafter all references in this Warrant to the location of its principal office at the
particular time shall be as so specified in such notice. All such notices and communications shall be deemed to have been delivered upon
the earlier of actual receipt, or (a) personal delivery to the party to be notified, (b) when sent, if sent by electronic mail or facsimile
during normal business hours of the recipient, and if not sent during normal business hours, then on the recipient’s next business
day, (c) five (5) days after having been sent by registered or certified mail, return receipt requested, postage prepaid, or (d) one
(1) business day after deposit with a nationally recognized overnight courier, freight prepaid, specifying next business day delivery,
with written verification of receipt.


 


10.
Rights as Stockholder. Until the exercise of this Warrant, the Registered Holder shall not have or exercise any rights by virtue
hereof as a stockholder of the Company. Notwithstanding the foregoing, in the event (i) the Company effects a split of the outstanding
shares of the same class and series as the Warrant Shares by means of a stock dividend and the Purchase Price of and the number of Warrant
Shares are adjusted as of the date of the distribution of the dividend (rather than as of the record date for such dividend), and (ii)
the Registered Holder exercises this Warrant between the record date and the distribution date for such stock dividend, the Registered
Holder shall be entitled to receive, on the distribution date, the stock dividend with respect to the Warrant Shares acquired upon such
exercise, notwithstanding the fact that such shares were not outstanding as of the close of business on the record date for such stock
dividend.








 


11.
Amendment or Waiver. Any term of this Warrant may be amended or waived only by an instrument in writing signed by the party against
which enforcement of the change or waiver is sought. No waivers of any term, condition or provision of this Warrant, in any one or more
instances, shall be deemed to be, or construed as, a further or continuing waiver of any such term, condition or provision.


 


12.
Section Headings. The section headings in this Warrant are for the convenience of the parties and in no way alter, modify, amend,
limit or restrict the contractual obligations of the parties.


 


13.
Governing Law. This Warrant shall be governed by, and construed in accordance with, the internal laws of the State of New York
without regard to the choice of law principles thereof that would result in the application of the laws of any other jurisdiction.


 


14.
Facsimile Signatures. This Warrant may be executed by facsimile signature.


 


[remainder
of page intentionally left blank]


 




    	8



     


    

 


EXECUTED
as of the Date of Issuance indicated above.


 


	 	CELCUITY
    INC.
	 	 	 
	 	By:	
	 	Name:	Brian
    F. Sullivan
	 	Title:	Chief
    Executive Officer


 




    	 



     


    

 


EXHIBIT
A


 


PURCHASE
FORM


 


	To:_________________	Dated:____________


 


The
undersigned, pursuant to the provisions set forth in the attached Warrant (No. ___), hereby elects to purchase __________________ Warrant
Shares covered by such Warrant.


 


The
undersigned herewith makes payment of the full purchase price for such shares at the price per share provided for in such Warrant, in
the amount of $______ in lawful money of the United States.


 


	 	 	 
	 	Signature:	 
	 	 	 
	 	Address:	 
	 	 	 
	 	 	 


 




    	 



     


    

 


EXHIBIT
B


 


ASSIGNMENT
FORM


 


FOR
VALUE RECEIVED, ________________________________________ hereby sells, assigns and transfers all of the rights of the undersigned under
the attached Warrant (No. ____) with respect to the number of Warrant Shares covered thereby set forth below, unto:


 


	Name
    of Assignee	 	Address
    and

    Electronic Mail Address	 	No.
                                            of

    Warrant
    Shares

	 	 	 	 	 
	 	 	 	 	 


 


	Dated:_____________________	 	 
	 	 	Signature
	 	 	 
	Signature
    Guaranteed:	 	 
	 	 	 
	By:
    _______________________